Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level Phase III data

  1. Daniel J Laydon  Is a corresponding author
  2. Ilaria Dorigatti
  3. Wes R Hinsley
  4. Gemma L Nedjati-Gilani
  5. Laurent Coudeville
  6. Neil M Ferguson
  1. Imperial College London, United Kingdom
  2. Sanofi-Pasteur, France
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/65131/elife-65131-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Daniel J Laydon
  2. Ilaria Dorigatti
  3. Wes R Hinsley
  4. Gemma L Nedjati-Gilani
  5. Laurent Coudeville
  6. Neil M Ferguson
(2021)
Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level Phase III data
eLife 10:e65131.
https://doi.org/10.7554/eLife.65131